Acadia Pharmaceuticals Inc. Registered Shares DL -,01

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

13.66%

Market Cap

2.81 Bil.

P/E Ratio

11.61

Dividend Yield

0.00 %

Earnings per Share

2.04 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE21.87 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 01:32:23 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW21.9821.75
PREV. DAY'S PRICE22.01 (07/20)
CHANGE DAY BEFORE
-0.14
-0.64 %
52 WEEK HIGH / LOW23.9 (12/22)17.14 (10/14)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-0.351.262.040.320.62
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-13.4811.6169.1936.06
PRICE - BOOK RATIO
11.944.173.71--
PRICE - SALES RATIO
7.063.194.24--
PRICE - CASH FLOW RATIO
307.1019.3641.32--
Further Key Figures

Master Data

WKN
603035
ISIN
US0042251084
SYMBOL
DR6
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Acadia Pharmaceuticals
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
164.77 Mil.
MARKET CAPITALISATION
2.81 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-1.03 %
18.24 %
18.02 %
-1.78 %
13.66 %
-21.95 %
7.47 %
-3.93 %
HIGH22.8123.1523.1523.5023.9028.8029.8023.65
LOW21.9418.6517.5117.3717.1412.2912.2017.37

Dividende

pro Aktie
Acadia Pharmaceuticals does not deliver dividend information

Company profile

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.